Acute and chronic postoperative pain and functional disability persisted among patients who underwent posterior spinal fusion despite multimodal analgesic management.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Common symptoms of chronic inflammation include fatigue, joint or muscle pain, long-lasting digestive issues, brain fog or ...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
When prescribing opioids for acute pain, physicians should be attentive to a patient’s individual risk factors, according to ...
In the second world war, the physician Henry Beecher observed that some of his soldier patients, despite being injured on the ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...
The Minnesota Department of Health has found that about 83,000 Minnesotans a year received chronic pain procedures during a three-year period. MDH was able to conduct this analysis for the ...
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
Most states allow some form of "medical marijuana." It is especially popular with pain patients, many of whom do not have ...
Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback